Vanda Isn’t Dropping This Bone Despite Negative Court Decision

Blog readers may be thinking, “HPM, didn’t you just blog about the Vanda case last week?” We certainly did (and had previously here and here). You will recall that Vanda Pharmaceuticals did not prevail in its quest to have the Court find that FDA’s imposition of a clinical hold due to requirements for certain dog studies that would require euthanizing the dogs was arbitrary and capricious. We have learned, however, that the company has not dropped its pursuit of change in the use of animals in preclinical studies.